Salicylanilide inhibitors of Toxoplasma gondii - sprookjes - yvandenbroek - TriplyDB

Salicylanilide inhibitors of Toxoplasma gondii

Salicylanilide inhibitors of Toxoplasma gondii

http://www.wikidata.org/entity/Q36401416

about

Clinically Available Medicines Demonstrating Anti-Toxoplasma Activity The benzimidazole based drugs show good activity against T. gondii but poor activity against its proposed enoyl reductase enzyme target Screening of the Open Source Malaria Box Reveals an Early Lead Compound for the Treatment of Alveolar Echinococcosis In silico design of anti-atherogenic biomaterials.Avalanche for shape and feature-based virtual screening with 3D alignment.Carbohydrate-derived amphiphilic macromolecules: a biophysical structural characterization and analysis of binding behaviors to model membranes.Modification of triclosan scaffold in search of improved inhibitors for enoyl-acyl carrier protein (ACP) reductase in Toxoplasma gondii.A Systematic Review of In vitro and In vivo Activities of Anti-Toxoplasma Drugs and Compounds (2006-2016).Drugs in development for toxoplasmosis: advances, challenges, and current status.Development of a triclosan scaffold which allows for adaptations on both the A- and B-ring for transport peptides.Application of Dendrimers for the Treatment of Infectious Diseases Antibacterial Activity of Salicylanilide 4-(Trifluoromethyl)-benzoates

P2860

Q26782581-899F7605-DAC9-40A1-8604-5205380470CD Q27681222-FC625CA5-0251-45C0-AC0E-CEAD7D97B778 Q28550703-0BB7520F-0D73-4DC8-BF3C-AFD8DFB289A3 Q34869890-E4235DD4-4318-435A-9D57-2B5FAA21D8D0 Q35803775-D9762F36-629E-4D34-BA0A-428D9A25F83C Q35824486-E878CBEA-6474-40C8-9F59-C0D553F93E76 Q37128281-25FF1004-8829-472F-9772-4888459EF4A1 Q37594988-9381CE94-3FA9-421E-9B95-004CE67D72F1 Q37613765-E35FCAEC-A26B-485F-ABED-DDE1F4BE7BC4 Q39420787-ACB25658-C77C-4C82-9A99-32A275B1A4FA Q58696083-897BFB9F-80ED-44BE-BF55-125352C83BE4 Q58851373-13099743-FE81-4DF5-9C3E-7DC030B422C6

P2860

Salicylanilide inhibitors of Toxoplasma gondii

http://www.wikidata.org/entity/Q36401416

description

2012 nî lūn-bûn

@nan

2012年の論文

@ja

2012年学术文章

@wuu

2012年学术文章

@zh-cn

2012年学术文章

@zh-hans

2012年学术文章

@zh-my

2012年学术文章

@zh-sg

2012年學術文章

@yue

2012年學術文章

@zh

2012年學術文章

@zh-hant

name

Salicylanilide inhibitors of Toxoplasma gondii

@ast

Salicylanilide inhibitors of Toxoplasma gondii

@en

type

label

Salicylanilide inhibitors of Toxoplasma gondii

@ast

Salicylanilide inhibitors of Toxoplasma gondii

@en

prefLabel

Salicylanilide inhibitors of Toxoplasma gondii

@ast

Salicylanilide inhibitors of Toxoplasma gondii

@en

P1433

Q36401416-34B00EE6-B03A-4C5C-9B93-34EDB31B2BB7

P1476

Q36401416-6E86A8BA-49A0-4F48-A5BD-C05524040E74

P2093

Q36401416-1DC15883-90B3-4081-A05C-CF744E3280C6

Q36401416-2B0E2500-8EE4-43E2-9333-CCEA081667F4

Q36401416-62D62D79-6586-41A7-9159-0E691E0C11D5

Q36401416-64D432B6-7211-484D-BEFA-C3F0DD1B6B5B

Q36401416-6D6E2937-D61E-42DD-900E-32FC24250A98

Q36401416-70590DC4-8707-43F4-B9C7-C239FD891761

Q36401416-8C86DC41-6F67-44AF-AAC1-3BE60B5523B4

Q36401416-8E82D6F7-A637-4C92-9FAB-86E701567C89

Q36401416-965126D8-25EE-42A4-882A-5B47638ECB2C

Q36401416-994E1860-3735-4416-9424-96AE94A59474

P2860

Q36401416-20DDFF0A-0A88-459A-847D-FC8F18458FF7

Q36401416-28D7CF11-C7C8-46D0-96D6-C3C23EAD4CD0

Q36401416-4691ABF0-B79D-416F-A081-EA830BFC8B9B

Q36401416-686D1E7E-8686-4CAA-90AC-B6B69D503800

Q36401416-8DFE7602-F787-47D0-B482-B64447D1BB74

Q36401416-909D0256-D867-4AB4-BCCC-3118CD059BC9

Q36401416-9FBEACD7-5A6E-49BB-9BAA-CC2F45A10176

Q36401416-A4FC69E0-3053-468B-9D0C-5F522E8C5458

Q36401416-C076C1C6-416A-496B-9704-9CFF7EDE0B30

Q36401416-D21FA7DE-0C71-4681-9750-D26DBE178403

P304

Q36401416-36DDB995-9479-4251-893C-2545583972AF

P31

Q36401416-CCFFDFBA-2AB9-4125-90EA-1881514B4FAD

P356

Q36401416-4A2772C3-9F50-4433-BD58-D001FBDB9819

P407

Q36401416-92AA9BCE-C7C3-402E-B8C2-3DCFFD394B64

P433

Q36401416-FBCA0A9E-E274-485D-B220-AA7B70C1662D

P478

Q36401416-2AAE0D67-E765-45C3-9CF4-53C05A61703E

P577

Q36401416-9B46ACE9-DB4A-43D9-909A-C2BC54631EF2

P698

Q36401416-E168F176-E195-4FF1-ACFA-DD9631473431

P921

Q36401416-9A07566B-3532-497C-A79A-4CF6C0C82064

P932

Q36401416-65F2538B-847C-4E02-805E-B621A36A637E

P356

P1433

Journal of Medicinal Chemistry

P1476

Salicylanilide inhibitors of Toxoplasma gondii

@en

P2093

Alina Fomovska

http://www.w3.org/2001/XMLSchema#string

Caroline Sommerville

http://www.w3.org/2001/XMLSchema#string

Craig Roberts

http://www.w3.org/2001/XMLSchema#string

Ernest Mui

http://www.w3.org/2001/XMLSchema#string

Jennifer M Auschwitz

http://www.w3.org/2001/XMLSchema#string

Jitenter P Dubey

http://www.w3.org/2001/XMLSchema#string

Leandra R Ferreira

http://www.w3.org/2001/XMLSchema#string

Mark R Hickman

http://www.w3.org/2001/XMLSchema#string

Patricia J Lee

http://www.w3.org/2001/XMLSchema#string

Richard D Wood

http://www.w3.org/2001/XMLSchema#string

P2860

Mechanism of action of reagents that uncouple oxidative phosphorylation

High prevalence and genotypes of Toxoplasma gondii isolated from goats, from a retail meat store, destined for human consumption in the USA.

Novel N-benzoyl-2-hydroxybenzamide disrupts unique parasite secretory pathway.

In silico activity profiling reveals the mechanism of action of antimalarials discovered in a high-throughput screen

Severe sulfadiazine hypersensitivity in a child with reactivated congenital toxoplasmic chorioretinitis.

Assessment and continued validation of the malaria SYBR green I-based fluorescence assay for use in malaria drug screening.

Triazine Inhibits Toxoplasma gondii tachyzoites in vitro and in vivo.

Outcome of treatment for congenital toxoplasmosis, 1981-2004: the National Collaborative Chicago-Based, Congenital Toxoplasmosis Study.

Impact of visual impairment on measures of cognitive function for children with congenital toxoplasmosis: implications for compensatory intervention strategies.

Experimental toxoplasma infection in mice with strains producing oocysts.

P304

8375-8391

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1021/JM3007596

http://www.w3.org/2001/XMLSchema#string

P407

P433

19

http://www.w3.org/2001/XMLSchema#string

P478

55

http://www.w3.org/2001/XMLSchema#string

P577

2012-09-26T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

22970937

http://www.w3.org/2001/XMLSchema#string

P921

Toxoplasma gondii

P932

3498903

http://www.w3.org/2001/XMLSchema#string